BG IRIS Research Client Login
Transactions
Services
Overview
Solutions
Sector expertise
Research
Insights
Overview
White Papers
Blog
Reports
Client Focus
About us
Overview
Senior Team
News
Events
Careers
Overview
Early careers
Experienced hires
Employee Growth Stories
Media
Press
Videos
Contact
Search
BG IRIS Research Client Login
ECM
Bryan, Garnier & Co successfully leads a follow-on offering with rights for Valtech
Bryan, Garnier & Co successfully leads Novagali Pharma €22m IPO
Bryan, Garnier & Co leads a Eur 152m capital increase for Transgene
Bryan, Garnier & Co successfully leads €6.7 million IPO for Integragen
Equity Issue SparebankenVest AS
Bryan, Garnier & Co leads a € 15,6 m capital increase for ExonHit Therapeutics
Bryan, Garnier & Co has successfully advised majority shareholder GRED in the public tender offer & squeeze out of Softway Medical
Bryan, Garnier & Co. announces it has advised ExonHit Therapeutics on the free allocation of subscription warrants to all its shareholders
Bryan, Garnier & Co. announces successful admission of ONI BioPharma Inc.’s common stock to listing and trading on NYSE Alternext Paris
Bryan, Garnier & Co successfully advised Pierrel on its EUR 17.1 million follow-on offering
1
…
11
12
13
14
15
Privacy Preference Center
Privacy Preferences